SERES THERAPEUTICS INC (MCRB) Stock Income Statement
NASDAQ:MCRB - Nasdaq - US81750R2013 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 144.93M | 33.22M | |||
| Operating Expenses | 118.05M | 189.49M | 179.91M | 209.42M | 121.34M | |||
| Research and Development | 61.87M | 114.12M | 109.65M | 141.89M | 90.57M | |||
| Selling, General, and Administrative Expenses | 52.64M | 75.38M | 70.26M | 69.26M | 30.77M | |||
| Operating Income | -118.05M | -189.49M | -179.91M | -64.49M | -88.13M | |||
| Interest Income/Expense | 3.97M | 4.83M | -2.96M | -40.00K | -1.98M | |||
| Other Income/Expense | 9.24M | 1.76M | -705.00K | -1.04M | 981.00K | |||
| Non Recurring Items | -20.93M | -7.23M | N/A | 0.00 | 0.00 | |||
| Income Before Taxes | -125.77M | -190.13M | -183.58M | -65.58M | -89.13M | |||
| Income Tax | 0.00 | 0.00 | 0.00 | N/A | N/A | |||
| Net Income | 136.00K | -113.72M | -250.16M | -65.58M | -89.13M | |||
| EBITDA | -112.58M | -183.25M | -173.28M | -58.55M | -81.55M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.00 | -0.88 | -2.31 | -0.72 | -1.12 | |||
| Non GAAP EPS | -0.97 | -0.90 | -2.34 | -0.72 | -1.15 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | -45.25% | -268.33% | |||
| Operating Profit Margin | N/A | N/A | N/A | -44.50% | -265.33% | |||
All data in USD